Latest filing published 05 Mar 2026 for NOVAVAX INC, €92k.
This profile gathers the share dealings of Ruxandra Draghia-Akli in Novavax Inc. We count 4 filings; the first trade dates from 11 November 2025 and the latest from 3 March 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 5 March 2026 with a share grant (€92k) in Novavax Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations